Quinoline derivatives for inhibiting histone methyltransferases and use thereof
Abstract:
The present disclosure relates to a quinoline derivative which inhibits the activity of histone methyltransferases (ESET/SETDB1) specific for the histone molecule H3K9 or a pharmaceutically acceptable salt thereof and a use thereof.
Information query
Patent Agency Ranking
0/0